Eric advises life sciences clients in the areas of new product planning, launch planning, competitive strategy and pricing, reimbursement and market access. His clients include both leading and emerging manufacturers of innovative and established biopharmaceuticals, vaccines, medical devices, clinical diagnostics, and animal health products. Eric’s specialty is advising on competitive strategy, helping clients to evaluate
Domenick advises biopharmaceutical, diagnostic, medical device, VC and private equity clients on new product strategies, therapeutic area strategies (including L&D), growth strategies, franchise strategic marketing, and pricing and reimbursement. He specializes in studies that leverage quantitative analysis, deep understanding of healthcare stakeholders, and sophisticated modeling, often involving primary research. He has supported commercialization of more
Paul advises biopharmaceutical and medical device clients on growth strategies, new product strategy, franchise strategic marketing, and pricing and reimbursement. He also serves as co-Chair of Putnam’s Talent Committee. During his consulting career, Paul has assisted pharmaceutical and biotechnology companies in business development, R&D strategy, product valuations, product launch planning, market assessments, forecasting and global
Scott Gilbert has served pharmaceutical and biotech clients across a wide range of specialty and primary care therapeutic areas in both domestic and international markets. Recent engagements have included pricing / managed markets strategy development, portfolio prioritization, medical adherence analysis, physician segmentation and opportunity analysis, and product forecasting. He has extensive expertise in advanced quantitative
John has been with Putnam Associates since 1992, and has over 21 years of strategy consulting experience. John has counseled senior executives at numerous leading pharmaceutical and biotechnology companies, providing strategic support and recommendations on a wide array of issues, including pricing, contracting and reimbursement strategies, corporate strategy, new product commercialization, clinical trial development, and
Remco specializes in helping life-sciences organizations develop global go-to-market and product lifecycle maximization strategies, addressing critical external stakeholder groups and leveraging internal functional expertise. He also serves as Putnam’s Boston Office Head. Since joining Putnam in 2000, Remco has served clients in the pharmaceutical, biotech and medical device industries on projects focused in both domestic
Matt serves leading clients within the life science industry on a range of commercial strategy issues. He has particular experience in helping his clients tackle complex challenges concerning pricing and market access strategy, product positioning and launch strategy, and market opportunity sizing and strategic direction setting. His practice is primarily focused in oncology, rare disease
Benjamin serves a range of life-science companies developing market opportunity assessments, global pricing and market access, therapeutic area, franchise, and product growth strategy, detailed forecasting, and market modeling. Benjamin has particular experience leading projects in oncology where he has mainly focused on both hematologic disorders (CML, MF, MM) and solid tumors (Pancreatic, Lung, Breast, and
Joseph serves major biopharmaceutical companies, developing strategies for pipeline agents, evaluating commercial opportunities, modeling detailed patient flows and treatment pathways, and optimizing plans for LCM/LOE. His clients span a wide range of therapeutic areas from oncology, cardiology, and hematology, to neurology and rheumatology, in addition to vaccines and diagnostics. Leveraging his experience with both pipeline
Since joining Putnam in 2007, Joia has worked across a range of therapeutic areas, including immunology, rare diseases, oncology, and vaccines. Her recent focus has been on product positioning and market opportunity identification for late-stage clinical pipeline products as well as for marketed products. She has extensive experience in assessing and translating complex clinical product
I work at the interface of clients, partners, and the analytical team, managing all of the work that goes into bringing our clients the most bulletproof deliverables possible. The best part of working here is the opportunity to join teams with so many dedicated, whip-smart professionals solving very demanding problems every day.
My work at Putnam allows me dovetail my scientific and technical expertise with my business acumen. Additionally, Putnam takes a rigorous approach to problem solving and tackles complex and challenging problems that impact the global healthcare industry.
I recently rejoined Putnam as a Manager in the San Francisco office. It is an exciting opportunity to help grow the new office and work with our west coast clients
91% of Putnam employees have worked on a case looking at global markets
My projects at Putnam dig deeply at the science of many of the biggest drugs, and then pivots into identifying or analyzing for business opportunities within the context of the science.
My role entails project and team management, frequent client contact and presentation of deliverables. Heading into my 5th year at Putnam, I continue to feel challenged and engaged. No two projects are the same.
Putnam has served 14 of the top 20 global biopharmaceutical companies since 2010
I work with the partners, team, and clients to draw insights from primary and secondary data and provide strategies for supporting clinical and commercial development of pharmaceutical products.
At Putnam, we get to collaboratively structure and solve challenging business problems for diverse brands. I enjoy the process of understanding the unique intricacies of the market landscape, uncovering insights from physician interviews, and conducting data analysis to generate meaningful recommendations for our clients.
At Putnam, I have served pharmaceutical clients across a wide range of therapeutic areas, including hematology, oncology, and women’s health, with a recent focus in vaccine forecasting and development strategy.
I enjoy the people I work with. Everyone brings a different style and essence to the team and watching it all come together is rewarding and fun
With Putnam, I am able to work on the cutting edge of the life sciences industry by helping to bring products to market and by supporting companies in navigating an ever-changing environment. For me, Putnam has been a great place to develop my business acumen while working in a field that I am passionate about.
The role of life sciences consultant is very exciting because it allows me to take on a wide range of different responsibilities. My role ranges from performing in-depth data analysis, to helping develop hypotheses and storylines for the overall project, to manage the workstreams of newer members of the team.
I value the experiences and opportunities I have had at Putnam and believe that the smart, motivated, and supportive colleagues and diverse project types make Putnam a really fantastic company to work for, learn from, and have fun with.
Since 2000, more than 1/4 of Putnam Associates who have gone on to MBAs have attended HBS
At Putnam, my role varies by project – but deep strategic analysis, laser focus on our clients’ goals, and sharp yet down-to-earth colleagues are all constants.
Putnam has given me an incredible opportunity to navigate some of the most interesting challenges in the healthcare space while working alongside smart, diligent colleagues. I’ve been able to leverage my deep background in basic science and knowledge of business to tackle challenging problems across different therapeutic areas.
As a former bench scientist, I find it exciting to work on projects that involve cutting-edge technologies and breakthrough therapies that have a direct clinical impact. I am able to leverage my research expertise by providing scientific and analytical insight into the development of business strategies that help our clients tackle challenging problems.
As a Life Sciences Consultant at Putnam, I work to solve problems for the healthcare industry.It is fantastic to be surrounded by a group of brilliant people, to pick up new knowledge on a daily basis, and to make an immediate impact on the real-world business.
Putnam was founded in 1988
Following my research in spine mechanics, my experiences at Putnam have enabled me to work across a range of therapeutic areas and provide clients with strategic guidance through the entire product life cycle. I am proud to be part of Putnam because of its commitment to addressing a variety of challenging projects in life sciences.
77% of Putnam projects are serving clients who have trusted us with important projects 5 + years
At Putnam, I use my biomedical research expertise and business proficiency to develop strategies and roadmaps for challenges faced by major players in global healthcare. Under less than a year at Putnam, I have worked on variety of projects including market access and commercialization, value demonstration, primary market research and market share forecasting.
Putnam Partners average 15 years of industry experience
Putnam focuses solely on the life science industries, allowing us to provide unparalleled depth, experience and insight into our client’s most complex challenges.
We do not define our client’s issue to fit our capabilities. Instead, we listen to their needs and tailor our comprehensive set of tools, techniques and expertise to quickly bring clarity to complex issues facing our clients.
Understanding the global challenges facing our clients enables us to provide customized, actionable and strategic recommendations that draw on deep therapeutic area and functional expertise.